These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 204058)

  • 1. A multicentric, randomized clinical trial of Gaviscon in reflux esophagitis.
    McHardy G
    South Med J; 1978 Jan; 71 Suppl 1():16-21. PubMed ID: 204058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
    Chevrel B
    J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of medical management of gastroesophageal reflux: a critical assessment.
    Hollander D; Karris G
    South Med J; 1978 Jan; 71 Suppl 1():41-2. PubMed ID: 204059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gastro-esophageal reflux. Treatment with Gaviscon].
    Ferrier JP; Chevrel B
    Med Chir Dig; 1978; 7(1):73-6. PubMed ID: 642629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
    Smart HL; Atkinson M
    J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reflux esophagitis treated with Gaviscon].
    Sigstad H
    Tidsskr Nor Laegeforen; 1979 Nov; 99(33):1733-4. PubMed ID: 531861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regurgitation esophagitis treated with Gaviscon].
    Jakobsen BM; Amdrup E
    Nord Med; 1968 Sep; 80(38):1243-5. PubMed ID: 4301892
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children.
    Forbes D; Hodgson M; Hill R
    J Pediatr Gastroenterol Nutr; 1986; 5(4):556-9. PubMed ID: 3016226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of gaviscon in the treatment of gastro-oesophageal reflux of infancy.
    Weldon AP; Robinson MJ
    Aust Paediatr J; 1972 Oct; 8(5):279-81. PubMed ID: 4349107
    [No Abstract]   [Full Text] [Related]  

  • 16. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.
    Yuan YZ; Fang JY; Zou DW; Levinson N; Jenner B; Wilkinson J
    J Dig Dis; 2016 Nov; 17(11):725-734. PubMed ID: 27622897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrogastrone for oesophagitis.
    Drug Ther Bull; 1979 Aug; 17(16):63-4. PubMed ID: 228924
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period.
    Markham C; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():73-82. PubMed ID: 6259715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.